4:18 PM ET
8-K
Business Update
Inovio Pharmaceuticals Business Update
INOVIO Pharmaceuticals provided a preliminary financial update for the quarter ended September 30, 2026, estimating its cash, cash equivalents, and short-term investments at approximately $48.4 million. This disclosure serves as a selective operational update ahead of its full quarterly financial report.
- Term
- Q3 2026